These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29753215)

  • 1. Expiratory and phonation times as measures of disease severity in patients with Multiple Sclerosis. A case-control study.
    Nordio S; Bernitsas E; Meneghello F; Palmer K; Stabile MR; Dipietro L; Di Stadio A
    Mult Scler Relat Disord; 2018 Jul; 23():27-32. PubMed ID: 29753215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of motor speech phenotypes in multiple sclerosis.
    Rusz J; Benova B; Ruzickova H; Novotny M; Tykalova T; Hlavnicka J; Uher T; Vaneckova M; Andelova M; Novotna K; Kadrnozkova L; Horakova D
    Mult Scler Relat Disord; 2018 Jan; 19():62-69. PubMed ID: 29149697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Articulatory speech measures can be related to the severity of multiple sclerosis.
    Kieling MLM; Finkelsztejn A; Konzen VR; Dos Santos VB; Ayres A; Klein I; Rothe-Neves R; Olchik MR
    Front Neurol; 2023; 14():1075736. PubMed ID: 37384284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separate and Combined Influence of Cognitive Impairment and Dysarthria on Functional Communication in Multiple Sclerosis.
    Feenaughty L; Tjaden K; Weinstock-Guttman B; Benedict RHB
    Am J Speech Lang Pathol; 2018 Aug; 27(3):1051-1065. PubMed ID: 30054632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
    Kragt JJ; Thompson AJ; Montalban X; Tintoré M; Río J; Polman CH; Uitdehaag BM
    Neurology; 2008 Mar; 70(13 Pt 2):1084-91. PubMed ID: 18184917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
    Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM
    Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between quality of life and dysarthria in patients with multiple sclerosis.
    Piacentini V; Mauri I; Cattaneo D; Gilardone M; Montesano A; Schindler A
    Arch Phys Med Rehabil; 2014 Nov; 95(11):2047-54. PubMed ID: 24835754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vocal symptoms and acoustic changes in relation to the expanded disability status scale, duration and stage of disease in patients with multiple sclerosis.
    Yamout B; Fuleihan N; Hajj T; Sibai A; Sabra O; Rifai H; Hamdan AL
    Eur Arch Otorhinolaryngol; 2009 Nov; 266(11):1759-65. PubMed ID: 19513739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
    Cadavid D; Cohen JA; Freedman MS; Goldman MD; Hartung HP; Havrdova E; Jeffery D; Kapoor R; Miller A; Sellebjerg F; Kinch D; Lee S; Shang S; Mikol D
    Mult Scler; 2017 Jan; 23(1):94-105. PubMed ID: 27003945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expiratory muscle strength training: speech production outcomes in patients with multiple sclerosis.
    Chiara T; Martin D; Sapienza C
    Neurorehabil Neural Repair; 2007; 21(3):239-49. PubMed ID: 17351085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative measures detect sensory and motor impairments in multiple sclerosis.
    Newsome SD; Wang JI; Kang JY; Calabresi PA; Zackowski KM
    J Neurol Sci; 2011 Jun; 305(1-2):103-11. PubMed ID: 21458828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.
    Rabadi MH; Vincent AS
    Disabil Rehabil; 2013; 35(22):1877-84. PubMed ID: 23600712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EDSS variability before randomization may limit treatment discovery in primary progressive MS.
    Zhang J; Waubant E; Cutter G; Wolinsky JS; Glanzman R
    Mult Scler; 2013 May; 19(6):775-81. PubMed ID: 23027880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lip and tongue function differently affected in individuals with multiple sclerosis.
    Hartelius L; Lillvik M
    Folia Phoniatr Logop; 2003; 55(1):1-9. PubMed ID: 12566761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E; Orsini M; Daures JP; Camu W
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Nagels G; Garmyn M; De Keyser J
    Mult Scler; 2012 Apr; 18(4):451-9. PubMed ID: 21952096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive-linguistic deficit and speech intelligibility in chronic progressive multiple sclerosis.
    Mackenzie C; Green J
    Int J Lang Commun Disord; 2009; 44(4):401-20. PubMed ID: 19294553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patients.
    Lanzillo R; Di Somma C; Quarantelli M; Ventrella G; Gasperi M; Prinster A; Vacca G; Pivonello C; Orefice G; Colao A; Morra VB
    Eur J Neurol; 2011 Dec; 18(12):1402-6. PubMed ID: 21585623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample.
    Idiman E; Uzunel F; Ozakbas S; Yozbatiran N; Oguz M; Callioglu B; Gokce N; Bahar Z
    J Neurol Sci; 2006 Jan; 240(1-2):77-80. PubMed ID: 16277993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.